Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68180-857

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68180-857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fbcf73ed 32b7 4f2c Abc2 Cf092f1db3c3 Figure 01

Chemical structure diagrams of the active ingredients Levonorgestrel (left) and Ethinyl Estradiol (right) shown in the image. Each structure is labeled with the respective name below the molecular diagram.*

FDA Label Image

Fbcf73ed 32b7 4f2c Abc2 Cf092f1db3c3 Figure 02

A bar chart comparing four groups—Ever-Users (Nonsmokers), Controls (Nonsmokers), Ever-Users (Smokers), and Controls (Smokers)—across four age groups (15-24, 25-34, 35-44, 45+). The chart shows the highest value for Ever-Users (Smokers) in the 45+ age group, with other groups and ages having lower values. The chart appears to present a comparative analysis of data by age and smoking status.*

FDA Label Image

Fbcf73ed 32b7 4f2c Abc2 Cf092f1db3c3 Figure 03

A forest plot chart depicting effect estimates (Odds Ratios/Relative Risks) with confidence intervals for various women's health studies from 2002 to 2017. Study names and years are listed on the left, with corresponding effect estimate points and confidence intervals plotted around a central reference line at 1.0 on the horizontal axis, and numeric values presented on the right.*

FDA Label Image

Fbcf73ed 32b7 4f2c Abc2 Cf092f1db3c3 Figure 04

An illustrated weekly medication tracker diagram arranged in four horizontal rows labeled Week 1 through Week 4, each row containing seven empty circular markers under days of the week from Sunday to Saturday. Arrows indicate the daily progression from one circle to the next, and an instruction to perform a monthly self breast exam is noted on the right side.*

FDA Label Image

Fbcf73ed 32b7 4f2c Abc2 Cf092f1db3c3 Figure 05

Levonorgestrel and Ethinyl Estradiol Tablets USP packaging label from Lupin Pharmaceuticals, Inc. The label shows the active ingredients and strengths: 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, and 0.125 mg/0.03 mg. It includes storage instructions and manufacturing information for Lupin Limited in India. The forming foil/PVC side displays a 28-day calendar layout with circles for each day and week, labeled Sunday through Saturday with a note for monthly self breast exam.*

FDA Label Image

Fbcf73ed 32b7 4f2c Abc2 Cf092f1db3c3 Figure 06

Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP, a triphasic regimen oral contraceptive. Each tablet contains varying doses: 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, and 0.125 mg/0.03 mg of levonorgestrel and ethinyl estradiol. The product is distributed by Lupin Pharmaceuticals, Inc., packaged as 3 blisters of 28 tablets each, with Lupin Limited as the manufacturer in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.